Jonathan Levitt, Co-Founding Partner of Frier Levitt, was recently quoted in a Pharmacy Times article discussing a panel that Jonathan participated on at the 2023 Advanced Topics for Oncology Pharmacy Professionals (ATOPP) Summit in New Orleans, Louisiana.
Jonathan provided valuable insights on the Inflation Reduction Act (IRA) and the need for pharmacy benefit manager (PBM) reform. He shed light on the lack of transparency surrounding pharmacy adherence metrics, specifically the undisclosed criteria used by PBMs to judge performance. Jonathan highlighted the significance of the Any Willing Provider Law (AWPL) in challenging the controversial direct and indirect remuneration (DIR) fees imposed by PBMs. His insights, experience, and legal successes in fighting for fair practices have resulted in substantial reimbursements for oncology hospitals and practices. As these critical healthcare issues continue to shape the industry landscape, Jonathan’s perspective adds valuable insights to the ongoing discussions on Capitol Hill.
Co-Managing Partner
